Overview

Single Dose CHG Pharmacokinetic Study

Status:
Completed
Trial end date:
2017-08-06
Target enrollment:
Participant gender:
Summary
A single 2% topical application of ReadyPrep® CHG was applied on either the abdomen (Treatment-1) or the groin (Treatment-2) whereas Treatment-3 consisted of a control treatment where the same procedure as Treatment-1 and -2 was performed, but without the topical application of ReadyPrep® CHG. The treatments were separated by a wash-out of 7 calendar days.
Phase:
Phase 1
Details
Lead Sponsor:
Medline Industries
Treatments:
Chlorhexidine
Chlorhexidine gluconate